DSIP
DSIP is a naturally occurring nonapeptide studied for sleep support, stress modulation, and slow-wave sleep enhancement.
Overview
DSIP (Delta Sleep-Inducing Peptide) is a naturally occurring nonapeptide first isolated during sleep-related research and studied for slow-wave sleep support and stress modulation. It is not FDA-approved for any indication.
The literature discussed in the source includes preclinical and limited human work suggesting deeper delta-wave sleep without large REM disruption, along with HPA-axis and stress-response effects. This page presents that discussion as an educational once-daily bedtime protocol.
At a Glance
Protocol
Suggested bedtime titration approach starting low and increasing weekly.
Inject once daily subcutaneously before bedtime to match the peptide's sleep-oriented use case. The main table below reflects the standard gradual approach; the source also mentions more speculative advanced escalation beyond 300 mcg. Human data are limited, so minimum-effective-dose thinking is appropriate.
Dose progression
Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.
How DSIP works.
DSIP was first characterized in sleep research and is discussed as a peptide that may enhance delta-wave sleep while leaving REM architecture relatively intact. Mechanistic discussion often includes GABAergic and opioid-system interactions as well as HPA-axis modulation.
Preclinical work and limited human studies support the idea of sleep normalization and stress-response moderation, but the total evidence base remains smaller and less definitive than the lore surrounding the peptide.
Effects
Observations from clinical or preclinical literature.
Caution
Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.
CoFactors
Life Factors
Complementary strategies for best outcomes.
Metrics
Day-to-day metrics worth tracking through the protocol.
- Sleep quality and duration - track sleep onset, total time asleep, and morning restfulness
- Daytime energy and cognitive clarity - monitor whether better sleep is translating into better daytime function
- Stress and mood - watch for changes in subjective stress burden
- Injection-site reactions - note redness, swelling, or discomfort
Labs
Baseline and periodic bloodwork to monitor systemic health during the protocol.
Supplies Calculator
Estimates assume the schedule defined for this peptide.
Dose Calculator
Dose Calculator
Preparation
Careful technique preserves potency. Solution should be clear — do not shake.
- Allow vial to reach room temperature for 15–20 minutes before reconstitution.
- Draw the chosen bacteriostatic water volume with a sterile syringe.
- Inject slowly down vial wall; avoid foaming.
- Gently swirl/roll until dissolved (do not shake).
- Label with reconstitution date and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.
- Use within 30 days; discard any unused solution after 30 days.
Technique
General subcutaneous guidance from clinical best-practice resources.
Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.
Storage
Notes
Notes
References
- PNAS (1977)Original characterization of delta sleep-inducing peptide.https://pubmed.ncbi.nlm.nih.gov/16592440/
- NeuropsychobiologyEarly human work on DSIP psychophysiologic properties.https://pubmed.ncbi.nlm.nih.gov/6633115/
- Annals of the New York Academy of SciencesStress-protective discussion of DSIP sequelae.https://pubmed.ncbi.nlm.nih.gov/15677401/
- Neuroscience and Biobehavioral ReviewsClassic DSIP review literature.https://pubmed.ncbi.nlm.nih.gov/6392951/
- CDCSubcutaneous injection route guidance.https://www.cdc.gov/vaccines/hcp/admin/downloads/YCTS-VaxAdmin-Subcut-injection.pdf
- NCBI BookshelfGeneral subcutaneous-injection best-practice guidance.https://www.ncbi.nlm.nih.gov/books/NBK596739/